Absci files Form 3 for CMO, Head of R&D Somaratne Ransi Mudalinayake
ABSI•Absci files initial beneficial ownership statement
Absci filed an initial beneficial ownership statement for Somaratne Ransi Mudalinayake, chief medical officer and head of R&D.
Related News
MGP Ingredients amends Wells Fargo-led credit agreement to add back up to $20 million in receivables losses to EBITDA through 2027
MGPI•
Griffon forms Veritage Brands joint venture with ONCAP combining AMES North America and Venanpri assets
GFF•
Agilysys CEO Ramesh Srinivasan sells USD 21.08 million in common shares
AGYS
